Emerging at the UK, retatrutide, a new compound , is sparking considerable buzz within the medical community regarding its ability for weight management . This dual GIP and GLP-1 agent agonist looks to deliver a substantial advantage over established therapies, showing promising results in preliminary clinical trials . Researchers suggest its parti